M&S - IFB - USP Operation Expert
Sanofi· Beijing
seen live 1 day ago
Background Sanofi has decided to invest in new, state-of-the-art production facilities for the entire insulin portfolio as part of the InsuLINK program, to ensure a future-oriented, sustainable, and reliable long-term supply for diabetes patients worldwide. Beijing, China (IFB
This link goes straight to the employer's workday page. Posted 5 days ago.We last confirmed it was open 1 day ago.